KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Assets (2016 - 2025)

Historic Assets for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $90.6 billion.

  • Amgen's Assets fell 136.43% to $90.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $90.6 billion, marking a year-over-year decrease of 136.43%. This contributed to the annual value of $90.6 billion for FY2025, which is 136.43% down from last year.
  • Per Amgen's latest filing, its Assets stood at $90.6 billion for Q4 2025, which was down 136.43% from $90.1 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Assets registered a high of $97.2 billion during Q4 2023, and its lowest value of $59.2 billion during Q1 2022.
  • Over the past 5 years, Amgen's median Assets value was $89.0 billion (recorded in 2023), while the average stood at $79.4 billion.
  • Per our database at Business Quant, Amgen's Assets tumbled by 805.71% in 2021 and then soared by 5223.97% in 2023.
  • Quarter analysis of 5 years shows Amgen's Assets stood at $61.2 billion in 2021, then rose by 6.47% to $65.1 billion in 2022, then soared by 49.19% to $97.2 billion in 2023, then dropped by 5.47% to $91.8 billion in 2024, then dropped by 1.36% to $90.6 billion in 2025.
  • Its Assets was $90.6 billion in Q4 2025, compared to $90.1 billion in Q3 2025 and $87.9 billion in Q2 2025.